Testimony and Comments

IPO’s Comments to China’s Supreme People’s Court on Its Draft Provisions on Several Issues Concerning the Application of Law in the Trial of Patent Civil Cases Involving Drug Marketing Review and Approval

IPO's Comments to China’s Supreme People’s Court on Its Draft [...]

By Hannah Denny|2020-12-15T08:58:51-05:00December 13th, 2020|Testimony and Comments|Comments Off

IPO's Comments to the China National Intellectual Property Administration on [...]

By Hannah Denny|2020-12-14T08:44:36-05:00December 10th, 2020|Testimony and Comments|Comments Off

IPO's Recommendations for USPTO Director Qualifications

By Hannah Denny|2020-12-08T13:13:37-05:00December 8th, 2020|Testimony and Comments|Comments Off

Comments on Discretion to Institute Trials before the Patent Trial [...]

By Hannah Denny|2020-12-04T08:15:59-05:00December 3rd, 2020|Testimony and Comments|Comments Off

IPO Comments to EPO Boards of Appeal on Amendment Addressing [...]

By Hannah Denny|2023-08-18T10:36:09-04:00November 25th, 2020|Testimony and Comments|Comments Off

IPO Comments to India’s High Court of Delhi on Its [...]

By Hannah Denny|2020-12-11T15:58:40-05:00November 5th, 2020|Testimony and Comments|Comments Off

IPO Comments to U.S. Trade Representative re: the National Trade [...]

By Hannah Denny|2020-11-04T09:52:48-05:00October 29th, 2020|Testimony and Comments|Comments Off

IPO Comments on China’s draft Measures for the Implementation of [...]

By Hannah Denny|2020-10-27T10:10:11-04:00October 25th, 2020|Testimony and Comments|Comments Off

IPO’s Comments to China’s State Administration of Market Supervision on [...]

By Hannah Denny|2020-10-20T11:46:59-04:00October 18th, 2020|Testimony and Comments|Comments Off

IPO’s Comments to China’s Ministry of Justice on Draft Guiding [...]

By Hannah Denny|2020-10-05T14:01:30-04:00September 30th, 2020|Testimony and Comments|Comments Off